Get started
Author

Palani Bharath

Observed name: Bharath Palani
ORCID: 0009-0004-0880-0851
Observed ORCID: 0009-0004-0880-0851
OpenAlex ID: A5124216613
Computational Elucidation of Potent Ligands Targeting Recalcitrant ALK G1202R‐Associated Double Mutations Underlying Lorlatinib Resistance
2026 · Palani Bharath, Mohanraj Gopikrishnan, et al. · ChemistrySelect
ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications
2026 · Palani Bharath, Sailakshmi Iyer, et al. · Cancer Chemotherapy and Pharmacology
Molecular docking and dynamics-based validation of multi-herb phytoconstituents revealing nephroprotective mechanisms in CKD
2026 · Gunasekaran Mounika, K.B. Pavithra, et al. · Research Journal of Biotechnology
PDF
Integrative network pharmacology, molecular docking, and molecular dynamics simulations reveal potential anticancer mechanisms of Syzygium cumini phytochemicals against oral squamous cell carcinoma
2026 · Srividhya Srinivasan, Palani Bharath, et al. · Natural Resources for Human Health
PDF
Nanoparticles, Microorganisms, and E-Waste: An Integrated Approach to Environmental Sustainability
2026 · Palani Bharath, Sivaprakasam Vignesh, et al. · Springer eBooks
Computational discovery of lead compounds targeting G1202R-based ALK triple mutations conferring lorlatinib resistance in EML4-ALK variant 3 non-small cell lung cancer
2026 · Palani Bharath, Sivaprakasam Vignesh, et al. · Journal of Applied Pharmaceutical Science
Works count: 6
Citation count:
H-index:
I10-index:
Year
Topic
Type